MedPath

Effects of Dosin in Helicobacter pylori infectio

Phase 2
Conditions
Helicobacter pylori infection.
Helicobacter pylori [H.pylori] as the cause of diseases classified
B 98.0
Registration Number
IRCT201209041957N3
Lead Sponsor
Research Institute for Islamic and Complementary Medicine, Tehran Unive
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

20-60 years old, documented helicobacter pylori infection and functional dyspepsia.
Exclusion criteria: pregnancy, breast feeding, duodenal or gastric ulcer, cancer or bleeding, usage of NSAIDs, corticosteroids, bismuth, antibiotics, proton pomp inhibitors and anticoagulants 4 weeks before the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Helicobacter pylori infection. Timepoint: Six weeks after beginning of intervention. Method of measurement: Urea Breath Test.
Secondary Outcome Measures
NameTimeMethod
Dyspepsia. Timepoint: Six weeks after beginning of intervention. Method of measurement: Dyspepsia questionnaire.
© Copyright 2025. All Rights Reserved by MedPath